Authorized Generic for PERFOROMIST® (formoterol fumarate) Inhalation Solution

According to FDA, an authorized generic is the same as the brand-name drug but does not use the brand name on the packaging. Formoterol Fumarate Inhalation Solution is indicated for the long-term, twice-daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Authorized Generic for
PERFOROMIST (formoterol fumarate) Inhalation Solution

NDC 0378-1631-93

Formoterol Fumarate product packaging.

Please see Full Prescribing Information for Formoterol Fumarate Inhalation Solution.